Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers

Authors

Katherine E Smentkowski, Thomas Jefferson UniversityFollow
Demetrius H. Bagley, Thomas Jefferson UniversityFollow
Scott G. Hubosky, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

8-1-2020

Comments

This article is the author’s final published version in Translational Andrology and Urology, Volume 9, Issue 4, August 2020, Pages 1809-1814.

The published version is available at https://doi.org/10.21037/tau.2019.11.28. Copyright © 2020 AME Publishing Company

Abstract

Ureteroscopic biopsy is an integral part of diagnosis of urothelial carcinoma of the upper urinary tract. It can be a technical challenge, but diagnostic rates have improved remarkably with refinements in surgical technique and specimen processing. Cytology aids with diagnosis and other urinary biomarkers continue to evolve, which may help further stratify patients for treatment. The current literature on the ureteroscopic biopsy and role of urinary biomarkers is reviewed and summarized below.

Recommended Citation

Smentkowski, Katherine E; Bagley, Demetrius H.; and Hubosky, Scott G., "Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers" (2020). Department of Urology Faculty Papers. Paper 62.
https://jdc.jefferson.edu/urologyfp/62

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID

32944544

Language

English